Neuroone Medical Technologies (NMTC) Change in Receivables (2020 - 2026)

Neuroone Medical Technologies (NMTC) has reported Change in Receivables for 7 consecutive years, with -$798418.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Receivables fell 150.46% year-over-year to -$798418.0; the trailing twelve-month figure through Jun 2026 stood at $1.1 million (up 367.68% YoY), and the FY2025 full-year result was $1.1 million, up 516.05% from the prior year.
• Change in Receivables declined to -$798418.0 in Q2 2026 per NMTC's latest filing, from -$764484.0 in the prior quarter.
• Across five years, Change in Receivables topped out at $2.2 million in Q4 2024 and bottomed at -$2.1 million in Q1 2025.
• Historically, Change in Receivables has averaged $63196.3 across 5 years, with a median of $11956.0 in 2022.
• The sharpest annual moves came in 2023 and 2025: Change in Receivables jumped 892.25% in 2023, then sank 16849.45% in 2025.
• Over 5 years, Change in Receivables stood at $62082.0 in 2022, then jumped by 775.29% to $543399.0 in 2023, then soared by 303.44% to $2.2 million in 2024, then slumped by 36.27% to $1.4 million in 2025, then sank by 157.15% to -$798418.0 in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered -$798418.0, -$764484.0, and $1.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.